Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 1/20 | 0.77 |
| ▸ | AKR1C2 | P52895 | 4/20 | 0.48 |
| ▸ | AKR1C1 | Q04828 | 4/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | KCNK2 | O95069 | 1/20 | 0.44 |
| ▸ | KCNK10 | P57789 | 1/20 | 0.44 |
| ▸ | PLK1 | P53350 | 4/20 | 0.43 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.43 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.43 |
| ▸ | CXCR1 | P25024 | 3/20 | 0.43 |
| ▸ | CXCR2 | P25025 | 3/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.40 |
| ▸ | BCL2A1 | Q16548 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6835634 | 0.89 | ALB (0.77) | ALBAKR1C2AKR1C1KDM4EHTT | |
| SCHEMBL6818627 | 0.87 | ALB (0.59) | ALBAKR1C2AKR1C1KDM4EKCNK2 | |
| SCHEMBL6830537 | 0.87 | ALB (1.00) | ALBAKR1C2AKR1C1KDM4EHTT | |
| SCHEMBL6813815 | 0.85 | PLK1 (0.57) | ALBAKR1C2AKR1C1KDM4EHTT | |
| SCHEMBL6821338 | 0.77 | ALB (0.60) | ALBAKR1C2AKR1C1KDM4EKCNK2 | |
| SCHEMBL6818067 | 0.76 | NPC1 (0.61) | ALBAKR1C2AKR1C1HTTKCNK2 | |
| SCHEMBL6353212 | 0.75 | AKR1C2 (0.66) | AKR1C2AKR1C1KCNK2KCNK10PLK1 | |
| SCHEMBL6835618 | 0.75 | ALB (0.62) | ALBAKR1C2AKR1C1POLBMEN1 | |
| SCHEMBL6819161 | 0.74 | ALB (0.79) | ALBAKR1C2AKR1C1PLK1MCL1 | |
| SCHEMBL6835722 | 0.74 | PLK1 (0.57) | ALBKDM4EHTTKCNK2KCNK10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | GABRD, GABBR1, GABRA1 | ALB 1417/4885AKR1C2 2596/4885AKR1C1 2161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.